Similar articles

• Drug of first choice in mild and moderate essential hypertension--clinical, hemodynamic and economic aspects.

  Lund-Johansen P. Lund-Johansen P. Acta Med Scand Suppl. 1979;626:69-72. Acta Med Scand Suppl. 1979. PMID: 34984 No abstract available.
• Prazosin in the treatment of hypertension.

  Kincaid-Smith P. Kincaid-Smith P. Med J Aust. 1977 Aug 27;2(2 Suppl):27-9. doi: 10.5694/j.1326-5377.1977.tb107761.x. Med J Aust. 1977. PMID: 21342 No abstract available.
• Prazosin in hypertension. Clinical studies with special reference to initiation of therapy.

  Turner AS, Watson OF, Brocklehurst JE. Turner AS, et al. Med J Aust. 1977 Aug 27;2(2 Suppl):33-7. Med J Aust. 1977. PMID: 21343 Clinical Trial. No abstract available.
• Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

  Brogden RN, Heel RC, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1977 Sep;14(3):163-97. doi: 10.2165/00003495-197714030-00002. Drugs. 1977. PMID: 143363 Review. No abstract available.
• [Updating hypotensive therapy, especially with beta-blocking agents].

  Ferrara E, Mantovani M, Giugni R. Ferrara E, et al. Clin Ter. 1981 Sep 15;98(5):561-7. Clin Ter. 1981. PMID: 6118216 Review. Italian. No abstract available.